Neurones S.A. (EPA:NRO)

Neurones Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	49.41	44.24	37.71	30.92
Depreciation & Amortization	15.9	15.41	14.94	15.32
Loss (Gain) From Sale of Assets	-0.35	-0.64	-0.02	0.02
Loss (Gain) From Sale of Investments	-0.82	-0.03	0.09	-
Stock-Based Compensation	4.39	3.36	1.99	1.61
Other Operating Activities	2.14	5.82	7.75	6.8
Change in Other Net Operating Assets	1.39	-13.19	2.05	12.62
Operating Cash Flow	72.08	54.97	64.5	67.29
Operating Cash Flow Growth	-	31.12%	-14.77%	-4.15%
Capital Expenditures	-17.98	-10.61	-6.58	-7.19
Sale of Property, Plant & Equipment	0.08	0.06	0.16	0.07
Cash Acquisitions	-4.61	-2.62	-5.08	-0.81
Divestitures	2.17	2.31	1.49	0.85
Investment in Securities	-1.22	-1.39	-0.6	-0.93
Investing Cash Flow	-21.57	-12.26	-10.62	-8.01
Long-Term Debt Issued	6.39	0.07	0.02	0.14
Long-Term Debt Repaid	-9.98	-7.14	-6.62	-6.74
Net Debt Issued (Repaid)	-3.59	-7.07	-6.61	-6.6
Issuance of Common Stock	0.06	-	0.09	-
Repurchase of Common Stock	-	-0.11	-	-1.23
Common Dividends Paid	-26.65	-24.22	-	-4.84
Other Financing Activities	3.12	-4.67	-0.49	1.62
Financing Cash Flow	-27.06	-36.08	-55.43	-11.05
Foreign Exchange Rate Adjustments	0.03	0.25	0.13	-0.17
Net Cash Flow	23.48	6.89	-1.42	48.05
Free Cash Flow	54.09	44.36	57.92	60.1
Free Cash Flow Growth	-	21.93%	-23.40%	-3.62%
Free Cash Flow Margin	7.30%	6.67%	9.99%	11.46%
Free Cash Flow Per Share	2.23	1.83	2.39	2.48
Cash Interest Paid	0.46	0.89	0.22	0.32
Cash Income Tax Paid	25.35	24.13	16.16	14.98
Levered Free Cash Flow	52.69	39.34	54.94	58.79
Unlevered Free Cash Flow	53.59	40.4	55.55	59.43
Change in Net Working Capital	-3.39	13.68	-6.09	-16.86

Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.